NHD

Nutrition & Health Development (NHD) is a Belgian life sciences company dedicated to the development and commercialization of innovative medical nutrition for patients suffering from rare metabolic diseases. Founded in 2014 and based in Ghent, the company focuses on addressing the specific nutritional requirements of patients with inherited metabolic disorders such as Phenylketonuria (PKU), Tyrosinemia, and Maple Syrup Urine Disease (MSUD). NHD's product portfolio consists of specialized medical foods that provide essential amino acids, vitamins, and minerals while excluding the specific nutrients that patients cannot safely metabolize. By leveraging advanced nutritional science, NHD aims to improve clinical outcomes and the overall quality of life for patients and their caregivers. The company operates primarily in the European market, providing high-quality, science-backed solutions for the long-term management of rare genetic conditions.